These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 34871436)

  • 1. Response to Letter to the Editor from Justin M. Gregory: "Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study".
    Demeterco-Berggren C; Ebekozien O; Levy CJ; Maahs DM
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1769-e1770. PubMed ID: 34871436
    [No Abstract]   [Full Text] [Related]  

  • 2. Letter to the Editor From Gregory and Moore: "Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study".
    Gregory JM; Moore DJ
    J Clin Endocrinol Metab; 2022 Mar; 107(4):e1763-e1764. PubMed ID: 34871421
    [No Abstract]   [Full Text] [Related]  

  • 3. COVID-19 Hospitalization in Adults with Type 1 Diabetes: Results from the T1D Exchange Multicenter Surveillance Study.
    O'Malley G; Ebekozien O; Desimone M; Pinnaro CT; Roberts A; Polsky S; Noor N; Aleppo G; Basina M; Tansey M; Steenkamp D; Vendrame F; Lorincz I; Mathias P; Agarwal S; Golden L; Hirsch IB; Levy CJ
    J Clin Endocrinol Metab; 2021 Jan; 106(2):e936-e942. PubMed ID: 33165563
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection.
    Tallon EM; Ebekozien O; Sanchez J; Staggs VS; Ferro D; McDonough R; Demeterco-Berggren C; Polsky S; Gomez P; Patel N; Prahalad P; Odugbesan O; Mathias P; Lee JM; Smith C; Shyu CR; Clements MA
    Diabetes Res Clin Pract; 2022 Dec; 194():110156. PubMed ID: 36400172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Age and Hospitalization Risk in People With Type 1 Diabetes and COVID-19: Data From the T1D Exchange Surveillance Study.
    Demeterco-Berggren C; Ebekozien O; Rompicherla S; Jacobsen L; Accacha S; Gallagher MP; Todd Alonso G; Seyoum B; Vendrame F; Haw JS; Basina M; Levy CJ; Maahs DM
    J Clin Endocrinol Metab; 2022 Jan; 107(2):410-418. PubMed ID: 34581790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comorbidities increase COVID-19 hospitalization in young people with type 1 diabetes.
    Mann EA; Rompicherla S; Gallagher MP; Alonso GT; Fogel NR; Simmons J; Wood JR; Wong JC; Noor N; Gomez P; Daniels M; Ebekozien O
    Pediatr Diabetes; 2022 Nov; 23(7):968-975. PubMed ID: 36054578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Symptoms and Glycemic Control in Young People With Type 1 Diabetes Following SARS-CoV-2 Infection: An Observational Study.
    Nimri R; Rachmiel M; Yackobovitch-Gavan M; Brener A; de Vries L; Fisch Shvalb N; Lazar L; Oren A; Jacobi-Polishook T; Shefer Averbuch N; Tenenbaum A; Mel E; Krepel Volsky S; Mouler M; Demol S; Shalitin S; Bello R; Phillip M; Lebenthal Y
    J Clin Endocrinol Metab; 2022 Jul; 107(8):e3264-e3272. PubMed ID: 35524727
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Letter to the Editor: CoVid-19 and type 1 diabetes: Every cloud has a silver lining. Searching the reason of a lower aggressiveness of the CoronaVirus disease in type 1 diabetes.
    Tatti P; Tonolo G; Zanfardino A; Iafusco D
    Diabetes Res Clin Pract; 2021 Nov; 181():108270. PubMed ID: 32540326
    [No Abstract]   [Full Text] [Related]  

  • 9. Association between Covid-19 vaccination and incidence of type 1 diabetes in China: Evidence from 14.14 million registered residents between 2007 and 2021.
    Liu C; Guo MN; Chai Z; Xin Z; Chen G; Zimmet PZ; Yang JK
    Diabetes Res Clin Pract; 2023 Jul; 201():110723. PubMed ID: 37209876
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical characteristics of hospitalized and home isolated COVID-19 patients with type 1 diabetes.
    Al Hayek AA; Robert AA; Alotaibi ZK; Al Dawish M
    Diabetes Metab Syndr; 2020; 14(6):1841-1845. PubMed ID: 32971511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. No effects of COVID-19 on the development of type 1 diabetes autoimmunity and no evidence of an increased frequency of SARS-CoV-2 antibodies in newly diagnosed type 1 diabetes patients relative to healthy subjects.
    Tiberti C; Nenna R; Tromba V; Filardi T; Petrarca L; Silvestri F; Fassino V; Montuori M; Mancino E; Lenzi A; Midulla F; Costantino F; Morano S
    Acta Diabetol; 2023 Oct; 60(10):1301-1307. PubMed ID: 37171699
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Covid-19 infection in children and adolescents and its association with type 1 diabetes mellitus (T1d) presentation and management.
    Karavanaki K; Rodolaki K; Soldatou A; Karanasios S; Kakleas K
    Endocrine; 2023 May; 80(2):237-252. PubMed ID: 36462147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic.
    Salmi H; Heinonen S; Hästbacka J; Lääperi M; Rautiainen P; Miettinen PJ; Vapalahti O; Hepojoki J; Knip M
    Arch Dis Child; 2022 Feb; 107(2):180-185. PubMed ID: 34045208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Diabetes Technology Use for Management of Type 1 Diabetes Is Associated With Fewer Adverse COVID-19 Outcomes: Findings From the T1D Exchange COVID-19 Surveillance Registry.
    Noor N; Ebekozien O; Levin L; Stone S; Sparling DP; Rapaport R; Maahs DM
    Diabetes Care; 2021 Aug; 44(8):e160-e162. PubMed ID: 34385347
    [No Abstract]   [Full Text] [Related]  

  • 15. Association of COVID-19 and Development of Type 1 Diabetes: A Danish Nationwide Register Study.
    Zareini B; Sørensen KK; Eiken PA; Fischer TK; Kristensen PL; Lendorf ME; Pedersen-Bjergaard U; Torp-Pedersen C; Nolsoe RLM
    Diabetes Care; 2023 Aug; 46(8):1477-1482. PubMed ID: 37276529
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Severity in pediatric type 1 diabetes mellitus debut during the COVID-19 pandemic.
    Güemes M; Storch-de-Gracia P; Enriquez SV; Martín-Rivada Á; Brabin AG; Argente J
    J Pediatr Endocrinol Metab; 2020 Dec; 33(12):1601-1603. PubMed ID: 33151178
    [No Abstract]   [Full Text] [Related]  

  • 17. COVID-19 as a Trigger for Type 1 Diabetes.
    Wang Y; Guo H; Wang G; Zhai J; Du B
    J Clin Endocrinol Metab; 2023 Aug; 108(9):2176-2183. PubMed ID: 36950864
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DKA and new-onset type 1 diabetes in Brazilian children and adolescents during the COVID-19 pandemic.
    Luciano TM; Halah MP; Sarti MTA; Floriano VG; da Fonseca BAL; Del Roio Liberatore R; Antonini SR
    Arch Endocrinol Metab; 2022 Mar; 66(1):88-91. PubMed ID: 35029857
    [TBL] [Abstract][Full Text] [Related]  

  • 19. People living with type 1 diabetes point of view in COVID-19 times (COVIDT1 study): Disease impact, health system pitfalls and lessons for the future.
    Tejera-Perez C; Moreno-Pérez Ó; Rios J; Reyes-García R
    Diabetes Res Clin Pract; 2021 Jan; 171():108547. PubMed ID: 33278422
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The COVID-19 pandemic and associated worsening of diabetic ketoacidosis presentation in youth.
    Gera S; Longendyke RL; Minich NM; Malay S; Wood JR
    Diabet Med; 2021 Oct; 38(10):e14610. PubMed ID: 34053098
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.